Skip to content

Influence of 10 Hz rTMS and noradrenergic modulation on motor learning in healthy humans

Influence of 10 Hz rTMS and noradrenergic modulation on motor learning in healthy humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004653
Enrollment
50
Registered
2013-01-16
Start date
2012-05-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Group 1: Atomoxetine + real-10Hz-rTMS (single dose of 60 mg Atomoxetine per os) Group 2: Placebo + real-10Hz-rTMS Group 3: Atomoxetine + sham-rTMS (single dose of 60 mg Atomoxetine per os) Group 4: Pl

Sponsors

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: healthy subjects, right handed, age between 18 - 45 years

Exclusion criteria

Exclusion criteria: left-handed, neurological diseases, psychiatric diseases, other medical diseases, brain injury, stroke, febrile seizures in the childhood, psychotropic medication, fine motor skills, implanted devices like cardiac pacemaker, any metal in the head, pregnancy, lactation

Design outcomes

Primary

MeasureTime frame
Assessment of motor potentials evoked by transcranial magnetic stimulation, potentials were recorded with surface EMG-electrodes from the first dorsal interosseus muscle of the left hand (peak-to-peak-amplitudes in mV): resting motor threshold, short-intracortical-inhibition, intracortical facilitation, stimulus response curve Measured by the raw data of the fingertapping task: target score (total number of correct responses), execution time (time required to the subsequent correct response in ms)

Countries

Germany

Contacts

Public ContactMatthias Sczesny-Kaiser

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH

matthias.sczesny-kaiser@rub.de02343023258

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026